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TRSegions coding for structural proteins of porcine reproductive and respiratory
syndrome virus (PRRSV) poses problems for molecular dissection of the virus replication process. We
constructed ﬁve mutant full-length cDNA clones with the overlapping regions unwound and 1 to 3 restriction
sites inserted between two adjacent ORFs (ORF1/2, ORF4/5, ORF5/6, ORF 6/7 and ORF7/3′ UTR), which
generated the recombinant viruses. Our ﬁndings demonstrated that 1) the overlapping structural protein
ORFs can be physically separated, and is dispensable for virus viability; 2) such ORF separations did not
interrupt the subgenomic RNA synthesis; 3) the plaque morphology, growth kinetics, and antigenicity of
these mutant viruses were virtually indistinguishable from those of the parental virus in cultured cells; and
4) these mutant viruses remained genetic stable in vitro. This study lays a foundation for further molecular
dissection of PRRSV replication process, and development of genetically tagged vaccines against PRRS.
© 2008 Elsevier Inc. All rights reserved.IntroductionPorcine reproductive and respiratory syndrome (PRRS) is char-
acterized by reproductive failure in pregnant sows and respiratory
problems in all ages of pigs (Albina, 1997; Christianson and Joo, 1994;
Done and Paton, 1995). PRRS was ﬁrst reported in the United States in
1987 (Keffaber, 1989), and it is still one of the most severe epidemic
diseases threatening the swine industry worldwide. This is particu-
larly true in China, where a highly pathogenic PRRS virus (PRRSV)
variant strain has been causing devastating epidemic, so-called
“porcine high fever disease (PHFD)”, for the past two to three years
(An et al., 2007; Tian et al., 2007; Tong et al., 2007). Traditional
vaccines displayed limited cross-protection efﬁcacy, and better PRRS
vaccine is in dire need to control PHFD.
PRRSV is further classiﬁed into two distinct genotypes, (European)
Type I (Wensvoort et al., 1991) and (North American type) II (Benﬁeld
et al., 1992). As a member of the Arteriviridae of the order Nidovirales
(Snijder and Meulenberg, 1998), PRRSV is similar to lactate dehy-
drogenase elevating virus (LDV), equine arteritis virus (EAV), and
simian hemorrhagic fever virus (SHFV) in terms of genomic structure,
the mechanisms employed for replication and transcription. PRRSV
genome is a single-stranded, positive-sense RNA of approximately
15 kb in length (Meulenberg et al., 1993), with a 5′ cap and 3′ poly(A)fectious Diseases, Shanghai
gricultural Sciences. No. 518
8 1818.
l rights reserved.tail. The genomic coding region was ﬂanked by terminal untranslated
regions (UTR), 5′- and 3′-UTR, which play key regulatory roles in the
viral life cycle (Shanmukhappa et al., 2000; Sun et al., 2007; Verheije
et al., 2001, 2002a). The genome includes at least 9 open reading
frames (ORFs), designated ORF1a, ORF1b, ORF2a, ORF2b, and ORF3–7.
ORF2–7 encode at least 7 structural proteins including glycoprotein 2
(GP2), GP3, GP4, GP5, Membrane (M) protein, Nucleocapsid (N)
protein, and the recently recognized ORF2b-encoded 73 amino acid
nonglycosylated (E) protein (Mardassi et al., 1996; Meulenberg et al.,
1993; Meulenberg, 2000; Mounir et al., 1995; Nelsen et al., 1999; Saito
et al., 1996; Thiel et al., 1993; Wootton et al., 2000; Wu et al., 2005).
The functions of the structural proteins play in the virus replication
process warrant further study. For instance, there is no experimental
evidence supporting the assumption that GP5 is the viral attachment
protein, while it is under debate if GP3 is a structural constituent of the
PRRSV virion (Mardassi et al., 1996; Meulenberg et al., 1993;
Meulenberg, 2000).
Arteriviral structural proteins are expressed through a set of co-
terminal subgenomic mRNAs (sgmRNA), which are believed to be
generated via a Nidovirus-speciﬁc, not yet fully-understood discon-
tinuous transcription. Several lines of evidence support two models:
a leader-primed transcription model, with another involving the
discontinuous extension of minus-strand RNA. Based on these
models, the transcription-regulating sequence (TRS, UUAACC for
PRRSV) of the Leader (5′ UTR in PRRSV) and the downstream Body
TRS (TRS-B), preceding the ORF coding region of the structural
protein in the viral genome play key roles in discontinuous
transcription (Pasternak et al., 2006). Base-pairing between the
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strand of the TRS-B mediates discontinuous jumping during synth-
esis of the minus-strand templates for EAV sgmRNAs (van Marle et
al., 1999). TRS-ﬂanking sequence could also affect nidoviral tran-
scription (Curtis et al., 2004; Nelsen et al., 1999; Pasternak et al.,
2004, 2006; Sola et al., 2005; Yount et al., 2006). In addition,
Pasternak et al. (2004) engineered several copies of a body TRS-
ﬂanking sequence cassette inserted into an EAV full-length clone-
derived replicon, and observed that sgmRNA abundance progres-
sively favor smaller RNA species, implying that downstream TRS-B
could exert negative effect on the upstream one.
The speciﬁc mechanism(s) underlying subgenomic RNA transcrip-
tion of PRRSV have not been elucidated clearly. For instance,
numerous TRS-like sequences exist in PRRSV genome, and non-
canonical TRSs were detected for all individual PRRSV sgmRNAs
(Nelson et al., 1993; Meng et al., 1995; Zheng et al., unpublished data).
In addition, the role of TRS-ﬂanking sequence plays for PRRSV
sgmRNA synthesis remains to be known.
The successful development of infectious clones of EAV (de Vries
et al., 2000; van Dinten et al., 1997) and PRRSV (Calvert et al., 2002,
2003; Fang et al., 2006a; Meulenberg et al., 1998; Nielsen et al., 2003;
Truong et al., 2004; Yuan and Wei, 2008) opens new avenue for
molecular dissection of the arteriviral RNA replication and transcrip-
tion. These infectious clones have also provided powerful tools for
the development of genetically engineered vaccines that can be
differentiable with PRRSV ﬁeld isolates, a desirable trait of vaccine for
ultimate eradication of PRRS. Furthermore, such reverse genetic
system (RGS) provides an excellent platform for functional dissection
of arteriviral structural proteins. However, it is known that variable
length of overlapping coding sequence shared by the adjacent ORFs
of the structural proteins. For example, an overlapping region of 255
nt exists between ORF3/4 of Type I PRRSV, while 15 and 10 nt span
the coding regions between ORF5/6 and ORF6/7, respectively (Meng
et al., 1995; Meulenberg and Petersen-den Besten, 1996; Morozov
et al., 1995; Nelsen et al., 1999). The biological signiﬁcance of these
overlapping regions on PRRSV replication is unknown. On the other
hand, such overlapping nature poses problem for genetic manipula-
tions of an individual structural protein ORF without affecting the
adjacent one. Aiming to deﬁne the cell tropism determinant, Verheije
et al. (2002b) constructed chimeric arteriviruses using Type I PRRSV
infectious clone as backbone expressing the terminal domains of EAV
GP5 and M protein, and found that these assumed viral attachment
protein GP5 or M failed to change cell tropism as expected. In
addition, these authors found that separation of the overlapping
regions was critical for viral viability for such chimeric viruses,
implying that arterivirus gene expression is tightly regulated. de
Vries et al. (2000) demonstrated that while the precise arrangement
of the overlapping regions for EAV structural proteins was also
necessary for viral infection, it was possible to rescue virus from
transfected cells when overlapping regions between ORF4/5, ORF5/6,
and ORF4/5/6 in EAV infectious clones were separated by inserting
polylinkers. Although numerous PRRSV infectious clones have been
successfully constructed (Calvert et al., 2002, 2003; Fang et al.,
2006a; Meulenberg et al., 1998; Nielsen et al., 2003; Truong et al.,
2004; Yuan and Wei, 2008), the issue of overlapping coding regions
of the structural proteins still impedes functional studies.
To facilitate further reverse genetic manipulation of PRRSV, we
investigated the importance of the arrangement of overlapping genes
of the structural proteins of a North American PRRSV (Yuan and Wei,
2008). We separated the overlapping sequences existing between the
beginning and end of ORF5/6 and ORF6/7, and inserted the restriction
enzyme sites (Pac I, Swa I, and Asc I) through a reverse genetic system
(RGS) approach based on an attenuated, PRRSV infectious clones
pAPRRS (Yuan and Wei, 2008). We also directly inserted Pac I, Swa I,
and Asc I sites between ORF1/2, and inserted a unique restriction
enzyme site (Nde I) between ORF4/5, and ORF7/3′ UTR. A series ofmutation viruses were recovered after transfection of cells using in
vitro RNA transcripts of the constructed full-length mutant DNA
clones. Our ﬁndings demonstrated that 1) the overlapping nature of
the coding regions for structural proteins is dispensable for the PRRSV
viability; 2) the insertion of foreign nucleotide sequence is feasible for
physical separation of the ORFs coding for structural proteins, and
such separation did not interrupt the subgenomic RNA synthesis; 3)
the plaque morphology, growth kinetics, and antigenicity of these
mutant viruses were virtually indistinguishable from those of the
parental virus in cultured cells; and 4) these mutant viruses remained
genetic stable for at least ﬁve passages in vitro culture system. This
study lays a foundation for further molecular dissection of PRRSV
replication process, and development of genetically tagged vaccines
against PRRS.
Results
Rescue of the PRRSV mutant virus with unwound ORF overlapping region
To facilitate PRRSV reverse genetic manipulation, and investigate
the signiﬁcance of the overlapping coding sequences of PRRSV
structural proteins, we generated a series of mutant plasmids with
overlapping regions separated by inserting 1 to 3 restriction sites. As
shown in Fig. 1, pORF12 had Pac I, Swa I, and Asc I sites inserted
between ORF1/2. Meanwhile, an Nde I restriction site was created 3
nucleotides (CAT) such that p5ND7 was constructed for separation of
ORF4/5, and pORF7Ua was constructed by inserting ATG between
ORF7/3′ UTR in similar manner. pORF56c and pORF673 were
constructed by inserting restriction sites (Pac I, Swa I, and Asc I) in
the tandem overlapping regions of ORF5/6 and ORF6/7. Sequencing
analysis revealed that these constructs were all consistent with the
original design, demonstrating that we had obtained a series of full-
length mutant plasmids with ORF overlapping regions separated and
inserted with restriction sites.
Typical PRRSV cytopathic effect (CPE) developed at day 4 post-
transfection inMarc-145 cells transfected with in vitro RNA transcripts
derived from all pORF12, p5ND7, pORF673, and pORF7Ua, while not in
mock-transfected control. The CPE developed in all ORF-separation
mutants resembled to that of the parental infectious clone, pAPRRS.
The supernatant of the cell culture containing the rescued viruses
were harvested and aliquoted, kept at −80 °C, and designated the
initial generation (P0). An aliquot (200 μl) of 1000 fold diluted P0 viral
liquid was used to infect fresh Marc-145 cells. The supernatant of cell
culture was harvested at 5dpi, designated P1, aliquoted and frozen.
Serial passage was conducted to generate passage P2–P5.
To prove that the rescued viruses were indeed from the tranfected
synthetic RNAs, IFA were conducted. As shown in Fig. 2, the
supernatant of the transfected cells contains PRRSV viruses, evidenced
by positive staining of the infected cells against Nsp2 monoclonal
antibody of PRRSV. In addition, the result indicated that all mutant
viruses including vORF12 (Panel A), v5ND7 (B), vORF56c (C), vORF673
(D), and vORF7Ua (E) shared the similar Nsp2 distribution pattern
with the parental virus (data not shown). These results demonstrated
that the rescued viruses from all full-length mutant cDNA clones were
PRRSV-speciﬁc, as no staining was detected in negative control (Fig. 2,
Panel F).
The mutant PRRSV viruses remained genetically stable in vitro
To further identify if the mutant viruses retained the designed
mutations and remained genetically stable during serial passage, P1
and P5 of the rescued viruses were used for RT-PCR and nucleotide
sequence analysis with primer pairs ﬂanking the mutation sites. The
correct size of RT-PCR products were ampliﬁed from all of the rescued
viruses for both passage level (data not shown), indicating there is no
dramatic disturbance in the insertion regions. Nucleotide sequencing
Fig.1.Genomic structure of the full-lengthmutant PRRSV cDNA clones. The boxed numbers 1a,1b, 2a, 2b, and 3 through 7 represented PRRSV open reading frame (ORF) 1a –ORF7. For
the mutant PRRSV clones, only the region covering the part of 1b through ORF7 and 3′ UTR is shown. The position and inserted nucleotide sequences are shown. The restriction sites
(Pac I, Swa I, Asc I, or Nde I) are underlined and labeled.
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P1 viruses of all rescued viruses (data not shown), indicating the latter
were indeed generated from the transfection of the synthetic RNAs
from the designed full-length mutant cDNA clones. Moreover,
nucleotide sequence comparisons between the corresponding regionsFig. 2. Indirect immunoﬂuorescence assay showed that the rescued viruses are PRRSV-speciﬁ
of which 0.01 MOI was inoculated on Marc-145 cells of cell dishes, and incubated at 37 °C
antibody of PRRSV (Kindly provided by Dr. Ying Fang at South Dakota State University) at 1:8
isothiocyanate-conjugated (FITC) secondary goat anti-mouse antibody, and visualized under
(D) vORF673, (E) vORF7Ua, and (F) negative control.of the mutant plasmid, P1, and P5 viruses showed that there were no
other mutations in the ﬂanking region (1–2 kb) of the inserted
restriction sites. These results demonstrated that the overlapping
nature of coding sequences between adjacent ORFs of the structural
proteins is not essential for virus viability, and is genetically stable inc. The supernatant of the transfected cells was collected and aliquoted as virus stock P0,
for 72 hpi. The infected cells were ﬁxed and then stained with anti-Nsp2 monoclonal
00 dilution in phosphate-buffered saline (PBS), followed by incubation with ﬂuorescein
Olympus inverted ﬂuorescence microscopy. Panel (A) vORF12, (B) v5ND7, (C) vORF56c,
25D. Yu et al. / Virology 383 (2009) 22–31at least the 1–2 kb ﬂanking region of the mutation site for at least ﬁve
passages in cultured cells.
The separation of overlapping regions does not alter the wild-type
virological characteristics of the mutant viruses
Genetic manipulation of the PRRSV structural protein coding
regions could affect virological properties. To address this, we
performed viral plaque morphological analysis of the ﬁfth passage
of the mutant viruses rescued from full-length mutant plasmids
pORF12, p5ND7, pORF56c, pORF673, pORF7Ua, and pAPRRS (Fig. 3A).
Virus plaque morphology remained essentially the same with that of
the parental virus, vAPRRS. Multiple-step growth curves of the
mutant viruses were measured by determining the virus titres (PFU/
ml) of the supernatant collected at the indicated time points. As
shown in Fig. 3B, the titer of the parental virus vAPRRS (□) was
consistently slightly higher than those of the ﬁve mutant viruses, and
peaked at 72 hpi. In contrast, the mutant viruses lagged 12 h in
reaching maximum titer. In particular, the peak titer of vORF56c (▽)
was 7.58×104 PFU ml−1 at 84 h, considerably lower than the1.51×106
PFU ml−1at 72 hpi of wild-type virus, indicating that the insertion
between ORF 5 and 6 could adversely affects the virus growing ability.
However, the overall pattern of the growth curve was consistent,
which suggests that insertion of 3–23 nt between the ORFs did not
lethally affect viral growth.Fig. 3. Themutant viruses retained similar virological properties of parental virus. (A).
Viral plaque morphology. Marc-145 cells in 6-well plate were infected with passage
5 viruses at an M.O.I of 0.1, or mock-infected with DMEM. The monolayer of infected
cells was overlaid with agarose, and stained with crystal violet at 5 dpi. (B). Viral
growth kinetics growth analysis. The infection was done as for viral plaque assay,
without agarose overlay. The cell supernatants were harvested at the indicated time
points, followed by viral titration by plaque assay on Marc-145. Based on viral titer
and timepoints, the growth curves were determined: vAPRRS (□), vORF7Ua ( ),
vORF673 (+), vORF56c (▽), v5ND7 (△), vORF12 (○).The rescued viruses maintain the PRRSV subgenomic RNA proﬁle
To further deﬁne if the mutant viruses retained the viral RNA
proﬁles in infected cells, northern blotting analysis was conducted
using a synthetic biotin-labeled probe complementary to the 3′ UTR,
shared by all viral RNA species. Consistent with the parental virus
vAPRRS, all mutant viruses produced at least seven sgmRNAs in the
Passage 5 virus infected cells (sgmRNA2–7, Fig. 4A). Additionally, two
subgenomic RNAs (Fig. 4A, black arrow) were also detected between
mRNA2 and genomic RNA, which are similar in size to some
heteroclite RNA molecules associated with PRRSV VR2332 strain
described previously (Yuan et al., 2000). These results indicated that
genetic manipulation of the structural gene-encoding region did not
impose visible changes to the viral mRNA pattern. However, the
abundance of individual mRNA species, especially sgmRNA2 and 3
(Fig. 4A, arrow head) of vORF56c is visibly lower than those of other
viruses, while the downstream sgmRNA7 and genomic RNA displayed
the same abundance.
We next assessed the impact of restriction site insertion on
mutant viral mRNA transcription, especially the utilization of the
respective TRS-B, to which the local ﬂanking sequence and secondary
structure could be altered because of the insertional mutations. To do
so, we designed the forward primer in the genomic leader region and
the reverse primer located in the individual ORF of the structural
protein, such that speciﬁc discontinuous jumping site of the Body
part to the Leader can determined. As shown in Fig. 5, The Leader–
Body junction of sgmRNA5 for v5ND7 (Fig. 5A), sgmRNA6 (Fig. 5B)
and sgmRNA6.1 (Fig. 5C) for vORF56c, and sgmRNA7.1 (Fig. 5D) and
sgmRNA7.2 (Fig. 5E) for vORF673 were determined by subgenomic
RNA-speciﬁc RT-PCR. Nucleotide sequence analysis of each RT-PCR
product revealed that the same TRS-B was employed for individual
sgmRNA synthesis by the respective mutant virus and the parental
virus (data not shown). Meanwhile, the inserted nucleotide
sequences were observed in their corresponding locations (Fig. 5,
boxed), except for vORF56c, of which the noncanonical TRS-B6.1
(Fig. 5C) located 255 nucleotides downstream the ORF6 start codon.
However, the same noncanonical TRS-B6.1 was also found in the
parental virus infected cells (Yuan et al., unpublished observation).
It remains further investigated if the TRS-B6.1 mediated sgmRNA
encodes, if any, a truncated form of M or extended sgmRNA7 and/or
nucleocapsid. Overall, these results suggesting that these mutations
did not deleteriously affect viral subgenomic transcription.
Discussion
As a relatively small RNA virus, arterivirus utilized a rather
sophisticated gene expression strategy in terms of genomic organiza-
tion, genomic and subgenomic RNA synthesis, mRNA translation, and
downstream virus replication process. Unlike its cousins of arter-
iviruses and coronaviruses in the same order Nidovirales, PRRSV
replication process and control thereof is poorly understood. It is not
yet known if PRRSV adopts the same transcriptional regulatory
mechanisms with other nido- or arteriviruses. It also remains further
investigation what roles the structural proteins play in the process of
PRRSV infection. As the most economically signiﬁcant swine disease, a
better vaccine based on reverse genetic manipulation would be of
particular interest to combat the ever-evolving pathogen.
To overcome the tight genomic organization of arterivirus, de
Vries et al. (2001) engineered recombinant EAV containing sepa-
rated ORF5/6 with overlapping sequences unwound as restriction
sites, in which a GFP was inserted with an EAV-speciﬁc transcription
regulation sequence. However, the recombinant EAV-GFP virus was
gradually lost during passage on cell culture. In the similar manner,
Groot Bramel-Verheije et al. (2000) successfully separated ORF6 and
7 of the prototypic European LV strain, sharing a mere 64%
nucleotide identity with North American type. These authors further
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fused with N- or C-terminus of the nucleocapsid protein, only to
found that HA gene loss was apparent by the second generation, and
was completely deleted by the fourth generation of the recombinant
virus, implying that the gene expression strategy is highly regulated.
In the present study, all of the designed mutant cDNA clones of a
North American PRRSV generated viable viruses, demonstrating that
the overlapping nature of the structural ORFs is dispensable for virus
viability. This is the ﬁrst report on physical separation of structural
protein coding regions of a North American type PRRSV, and
provided a platform for further dissection of virus replication and
developing genetically engineered vaccine.
Although the mutant viruses shared the similar characteristics
with their parental virus, it was apparent that the growth rate of
vORF56c is decreased comparing with vORF673, in which the same
three restriction siteswere inserted between ORF5/6 and ORF6/7. Viral
plaque assay and IFA results revealed no signiﬁcant virological
differences between ORF56c and other viruses. However, as shown
in Fig. 4A, the insertion between ORF5/6 might adversely affected
synthesis of the upstream sgmRNA2 and 3. Paradoxically, the
sgmRNA4 abundance was increased during the ORF5/6 insertion.
Though quantitative study is warranted to measure the relative mRNA
abundance, it appeared that insertion into certain region of the PRRSV
may disturb the relative sgmRNA levels and thus virus production.
These results implying that the insertion site and/or sequence nature
of the inserted gene has to be selective for attempt to use PRRSV as an
expression vector.
Although TRS-L and complementary TRS-B base-pairing plays key
roles in the discontinuous transcription process of CoV and
Arterivirus sgmRNA (Pasternak et al., 2006; van Marle et al., 1999),
these are not the only factors affecting nidoviral transcription.
Indeed, the ﬂanking sequences of TRS inﬂuence sgmRNA transcrip-
tion (Curtis et al., 2004; Nelsen et al., 1999; Pasternak et al., 2004,
2006; Sola et al., 2005; Yount et al., 2006). de Vries et al. (2000)
discovered an novel atypical sgmRNA5.2 from a recombinant EAV
containing foreign sequence between ORF5 and ORF6, indicating the
landscape for certain sgmRNA synthesis can be changed by
insertional mutation and thus activate cryptic or new TRS. The
recombinant PRRSVs described in this study did not produce
detectable novel subgenomic RNA, but insertion between ORF5/6
might cause the down- or up-regulation of the upstream sgmRNA2/3
and 4, respectively. Curiously, the same insertion sequence inserted
between ORF6/7 barely affected virus replication. It implies that the
39 nt insertion of into ORF5/6 locus induces changes of local
secondary structure and spatial relationship with some yet-
unknown upstream transcription-regulating elements. Using the
energy minimization program of Mfold Web server (http://frontend.
bioinfo.rpi.edu/applications/mfold/cgi-bin/rna-form1–2.3.cgi) (Zuker,
2003) and the secondary structure drawings of RNA molecules by
RnaViz version 2 (De Rijk et al., 2003), we conducted local secondary
structure prediction to all mutation sites including all TRS and ﬂanking
sequence. Compared with the native structure (Fig. 4B), ORF5/6
insertion induces a major branched stem-loop structure (Fig. 4C),
among other minor changes. All other mutations did not induce major
changes in terms of the overall structure, number and position of
stem-loops, as well as the TRS position, which is always located on
loop area (data not shown).
Infectious cDNA-based replicon vector is becoming a powerful tool
for dissecting virus replication process, and as an expression vector forFig. 4. Subgenomic RNA transcription remains largely unchanged. (A) Northern blot: Marc-
parental virus. The total intracellular RNAs were extracted at 24 hpi by RNAwiz. Ten μg of
northern blot was conducted by using NorthernMax kit (Ambion) with the biotin-labeled o
mRNAs 2 to 7 (sgmRNA2-7) produced by vAPRRS, vORF12, v5ND7, vORF56c, vORF673, vOR
indicated the sgmRNA2 and 3 produced by vORF56c. Predicted secondary structure of the TR
insertion, boxed are the induced extra branched stem-loop structure.gene of interest. Because of a series of sgmRNAs are employed,
nidovirus is attractive vector in that multiple GOIs can be express
theoretically. Unlike coronaviruses containing numerous accessory
genes for virus replication, arterivirus has a rigid icosahedral
nucleocapsid and overlapping coding regions, it proves to be difﬁcult
to ﬁnd an optimal locus for GOI expression. Numerous studies have
been directed utilizing the nonstructural protein 2 (nsp2) coding
region, themost variable part of PRRSV genome, as a GOI insertion site
(Fang et al., 2006b; Han et al., 2007; Kim et al., 2007). In most cases,
the inserted genes were modiﬁed and/or chewed out during further
serial passage, maybe due to the fact that nsp2 and its fusion form
have to be under proteolytic processing during nsp maturation. In
our study, we developed a platform that can be potentially used to
express GOI between ORFs coding for structural proteins. In
addition, these mutant cDNA clones would be of great value for
making chimeric PRRSV as vaccine candidate. Using an attenuated
PRRSV derived infectious cDNA as the backbone, one can readily
swap in the immuno-protective protein(s) easily. Such chimeric
virus vaccine would be genetically tagged, and powerful to combat
the ever-changing PRRSV (Wang et al., 2008).
Taken together, we conclude that 1) the overlapping structural
protein ORFs can be physically separated, and is dispensable for virus
viability; 2) such ORF separations did not interrupt the subgenomic
RNA synthesis; 3) the plaque morphology, growth kinetics, and
antigenicity of these mutant viruses were virtually indistinguishable
from those of the parental virus in cultured cells; and 4) these mutant
viruses remained genetic stable in vitro. This study lays a foundation
for further molecular dissection of PRRSV replication process, and
development of genetically tagged vaccines against PRRS.
Materials and methods
Cells and viruses
Marc-145 cells (ATCC, Manassas, VA) were propagated in DMEM
with 6% fetal bovine serum (Gibco-BRL, Gaithersburg, MD) and
maintained in DMEM with 2% fetal bovine serum at 37 °C with 5%
CO2. The Type II PPRSV virus, derived from the infectious clone
pAPRRS (Gao et al., 2007; Sun et al., 2007; Yuan and Wei, 2008) was
used as a wild-type (wt) control in all experiments.
Construction of mutant plasmid
The oligonucleotide primers were designed using Oligo6.0 soft-
ware based on PRRSV genomic sequences (GenBank accession
number: AF184212) and synthesized. Five pairs of primers (Table 1)
containing restriction sites were designed using pAPRRS as a
template and based on PRRSV genomic sequences. Site-speciﬁc
mutations were created using the QuikChange® II XL Site-Directed
Mutagenesis kit (Stratagene) according the manufacturer's recom-
mendations with modiﬁcations. Brieﬂy, oligonucleotide primers were
designed such that the foreign insertion sequence were incorporated
at the 5′ end or in the middle of the primer, leaving at least 10
nucleotides at the 3′ end matching with the template sequence. Using
circular plasmid DNA as the template, PCR were run as descried in the
instruction manual of the QuickChange mutagenesis kit. The plasmid
template was eliminated by Dpn I digestion (New England Biolabs,
Ipswitch, MA), followed by transformation of Top 10 competent cells
(Invitrogen) with the digested PCR mixture. The intermediate plasmid145 in 60 mm dishes were infected with passage 5 (1.0 MOI) of each mutant virus and
RNAs for each sample were separated on denaturing agarose gel electrophoresis, and
ligo probe complementary to 3′ UTR. The viral genomic RNA (gRNA) and subgenomic
F7Ua are shown. Arrows point to the heteroclite-like subgenomic RNAs; Arrow heads
S-B6 region by MFOLD program: (B) native TRS-B6 region; C vORF56c TRS-B6 plus 39 nt
Fig. 5. The mutant viruses utilized the native canonical TRS-B for sgmRNA transcription. Leader–Body Junction sequences of v5ND7 RNA 5, vORF56c RNA 6, and vORF673 RNA 7 were
RT-PCR ampliﬁed using forward primer in leader region and reverse primer in the respective ORF, followed by nucleotide sequencing of the sgmRNA-speciﬁc PCR product. The upper
strand in the alignments represents the TRS-L region of the genomic leader sequence, and the lower strand with trace ﬁle is the mRNA sequence, fromwhich the individual TRS-B is
indicated. The broken line box denotes the inserted sequence, and arrowheads indicate the jumping direction of Leader–Body. (A) Leader–Body fusion site of mRNA5 fromv5ND7; (B)
Leader–Body fusion site of mRNA6 vORF56c, and (C) mRNA 6.1 from vORF56c; (D) Leader–Body fusion site of mRNA7.1, and (E) mRNA 7.2 from vORF673.
28 D. Yu et al. / Virology 383 (2009) 22–31was screened and veriﬁed by restriction enzyme mapping and
nucleotide sequencing, and the target region were swapped into
the pAPRRS backbone treated with the same restriction enzymes,resulting in the ﬁnal full-length mutant clone. The puriﬁed full-length
mutant plasmid was all veriﬁed by PCR, restriction enzyme digestion
and nucleotide sequencing.
Table 1
Primers used for PCR
Namea Sequence (5′–3′)b Positionc Application
ORF12F TTAATTAATTTAAATGGCGCGCCAATGAAATGGGGTCCATGC 12182–12223 PCR to insert Pac I Swa I and Asc I between ORF1 and 2
ORF12R GGCGCGCCATTTAAATTAATTAATCAATTCAGGCCTAAAGTTGG 12160–12203
NDE5F CTGTTGGCAGTTTGACATATGTTTAAGTATG 13872–13902 PCR to insert CAT between OPF4 and 5
NDE5R CATACTTAAACATATGTCAAACTGCCAACAG 13872–13902
ORF56F TTAATTAATTTAAATGGCGCGCCATGGGGTCGTCCCTAGACGACTTTTG 14484–14532 PCR to separate ORF5 and 6
ORF56R GGCGCGCCATTTAAATTAATTAAGTTATTTGGCATATTTAACT 14484–14532
ORF67F TTAATTAATTTAAATGGCGCGCCTATGCCAAATAACAACGGC 14997–15015 PCR to separate ORF6 and 7
ORF67R GCCGTTGTTATTTGGCATAGGCGCGCCATTTAAATTAATTAA 14997–15015
NDUF AGCATGATGGGCTGGCATATGTCTTGAGGC 15363–15389 PCR to insert ATG between OPF7 and 3′ UTR
NDUR GCCTCAAGACATATGCCAGCCCATCATGCT 15363–15389
SF10989 ATTTAGGGCCACAGACAAGCG 10989–11009 Analytical RT-PCR for vORF12
SR12709 CCCCGTCATGCGCAGGTTGTGTAG 12709–12686
SF12670 CTCTCGGCTACCCATGCTACAC 12670–12691 Analytical RT-PCR for v5ND7
SR14365 ACCGCCAACGATAGAGTCTGCCCTTAGTGTCC 14365–14397
SF14413 CTGATCGACCTCAAAAGAGTTGTGCTTG 14413–14440 Analytical RT-PCR for vORF56c, vORF673, vORF7Ua and vAPRRS
SR15497 CAATTAAATCTTACCCCCACACGGTCG 15497–15524
SFSGM GTATAGGTGTTGGCTCTATGC 6–26 PCR for the sgmRNA
SR14234 GCGTAGATGCTACTCAGGACATACC 14210–14234 PCR for sgmRNA5
SR14880 ATGCGTGGTTATCATTTGCCGTAATC 14855–14880 PCR for sgmRNA6
SR15306 CTCCACAGTGTAACTTATCCTCC 15284–15306 PCR for sgmRNA7
a Primer names are organized in groups. Preﬁxes: RT, reverse transcription primer; SF, forward PCR primer; SR, reverse PCR primer.
b Restriction sites introduced by PCR are underlined.
c The nucleotide positions within the viral sequence are based on GenBank accession number AF184212.
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Mutant plasmids were isolated using a QIAprep Spin Miniprep kit
(Qiagen, Hilden, Germany) followed by identiﬁcation by electrophor-
esis, restriction enzyme map identiﬁcation. The full-length mutant
clones were linearized by cleavage with the restriction enzyme Xho I
that cuts downstream of the poly (A) tail, followed by recovering with
a QIAquick PCR Puriﬁcation kit (Qiagen, Hilden, Germany). RNA was
synthesized by a T7 mMessage Machine Kit (Ambion INC, Austin, TX)
using puriﬁed linearized-plasmid as template according to manufac-
turer's protocol, and including treatment of the RNA with DNase to
remove input plasmid. The RNA was dissolved in nuclease-free water.
2×105 cell well−1 Marc-145 cells were seeded into a 6-well plate and
grown for 2 days to approximately 60–80% conﬂuence before
transfection. The subconﬂuent cells were transfected with the RNA
transcribed in vitro using the DMRIE-C reagent (Invitrogen, Carlsbad,
CA), and incubated at 37 °C under 5% CO2. PRRSV-speciﬁc cytopathic
effect (CPE) was monitored daily. When the percentage of cytopathic
cells exceeded 90%, the supernatant was harvested and stored at
−70 °C. The post-transfection cells were serially passaged 5 times as
virus stock for use in further growth curves and plaque assays as
described previously (Yuan and Wei, 2008).
Plaque assay
The viral suspensionwas serially 10-fold diluted, and 200 μl viruses
were inoculated onto Marc-145 monolayers. After 1 h incubation at
37 °C, the cell monolayers were then overlaid with Modiﬁed Eagle
Medium (MEM) (2×) containing 2% low melting agarose (Cambrex,
Rockland, ME) and 4% fetal bovine serum and incubated for 5 days at
37 °C with 5% CO2. The resulting plaques were stained by crystal violet
(5% w v−1 in 20% ethanol).
Growth curve of virus
Marc-145 cells were infected with a low multiplicity of infection
(MOI), and 200 μl of the cell supernatant was harvested at different
time points (6 h, 12 h, 24 h, 36 h, 48 h, 72 h, 84 h, 96 h, 108 h, and
120 h) and stored at −70 °C. Viral titration was performed by plaque
assay, and a growth curve was determined from the plaque number
results as described previously (Gao et al., 2007).Indirect immunoﬂuorescence analysis
Marc-145 cells were infected with a lowmultiplicity of infection by
primary passage (P0) of the rescued virus (MOI), incubated for 72 hpi.
The cell monolayer was washed twice by PBS, followed by ﬁxation in
cold methanol for 10 min at room temperature. The ﬁxed cells were
processed by 0.1% BSA at room temperature for 30 min, and then
incubated at 37 °C for 2 h with anti-Nsp2 monoclonal antibody of
PRRSV (Kindly provided by Dr. Ying Fang at South Dakota State
University) at 1:800 dilution in phosphate-buffered saline (PBS). After
three washes with PBS, cells were incubated at 37 °C for 1 h with
ﬂuorescein isothiocyanate-conjugated (FITC) secondary goat anti-
mouse antibody. Finally, cells were washed ﬁve times with PBS and
visualized under Olympus inverted ﬂuorescence microscope ﬁtted
with a camera.
RNA extraction and RT-PCR
Viral RNA was isolated using a Viral RNA Mini Kit (Qiagen, Hilden,
Germany) according to manufacturer's instruction, and suspended in
RNase-freewater, quantiﬁed by UV spectrometer, aliquoted and stored
at −70 °C. One-step RT-PCR was performed using a commercial kit
(Takara, Dalian, China) according to the protocol in the accompanying
manual. The primers and PCR conditions used are listed in Table 1 to
detect PRRSV overlapping mutant virus. The PCR products were
identiﬁed by electrophoresis and sequencing.
sgmRNA5–7 of v5ND7, vORF56c, and vORF673 were ampliﬁed by
RT-PCR using RevertAidTM M-MuLV Reverse Transcript kit (MBI
Fermentas, St.Leon-Rot, Germany) and LA Taq (Takara). The reserve
transcription primers and PCR primers used are listed in Table 1. The
PCR products were gel puriﬁed, subcloned, and followed by nucleotide
sequencing.
Northern blot analysis
Monolayers of Marc-145 cells were infected with 1.0 MOI of P5
virus stock of eachmutant virus. Total intracellular RNAswere isolated
from infected cells harvested at 24 hpi using RNAWiz (Ambion, Austin,
TX) according to the manufactures instruction, and 10 μg of total RNAs
for each sample were separated on denaturing agarose gels using
Agarose-IE (Ambion, Austin, TX) as described previously (Yuan and
30 D. Yu et al. / Virology 383 (2009) 22–31Wei, 2008). Northern Blot was performed with the NorthernMax kit
(Ambion) according to manufacturer's protocol. Brieﬂy, the gel-
separated total cellular RNAs were transferred to a BrightStar-Plus
membrane (Ambion, Austin, TX) for 10 h, cross-linked by UV light,
prehybridized, and probed with a 3′ UTR-speciﬁc oligonucleotide
(VR3: 5′ AATTTCGGCCGCATGGTTTTCGCCAATTAAATCTTACCCCCA-
CACGGTCGC 3′). The hybridization was incubated at 42 °C overnight,
followed by washing with low-stringency buffers (Ambion, Austin,
TX). The ﬁlters were incubated with alkaline phosphatase-conjugated
streptavidin, and incubated with the chemiluminescent substrate
CDP-STAR (Ambion, Austin, TX), overlaid with Kodak ﬁlm.
Acknowledgments
We thanks Dr Jinyong Wang, Ms Fei Gao for helpful discussions;
This project was co-sponsored by the Natural Science Foundation of
China (#30530580), the Pujiang Talent program of Shanghai Munici-
pal Government (06PJ14118), the National Institute Non-proﬁt
Research Program, MOST (2005DIB4J051), the National Basic Research
Program (2005CB523202), and the Elite Researcher Homecoming
Program, Ministry of Human Resource (2006-Z3).
References
Albina, E., 1997. Epidemiology of porcine reproductive and respiratory syndrome
(PRRS): an overview. Vet. Microbiol. 55 (1–4), 309–316.
An, T.Q., Zhou, Y.J., Liu, G.Q., Tian, Z.J., Li, J., Qiu, H.J., Tong, G.Z., 2007. Genetic diversity
and phylogenetic analysis of glycoprotein 5 of PRRSV isolates in mainland China
from 1996 to 2006: coexistence of two NA-subgenotypes with great diversity. Vet.
Microbiol. 123 (1–3), 43–52.
Benﬁeld, D.A., Nelson, E., Collins, J.E., Harris, L., Goyal, S.M., Robison, D., Christianson,
W.T., Morrison, R.B., Gorcyca, D., Chladek, D., 1992. Characterization of swine
infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J. Vet.
Diagn. Invest. 4 (2), 127–133.
Calvert, J.G., Sheppard, M.G., Welch, S.-K.W., 2002. Infectious cDNA clone of North
American porcine reproductive and respiratory syndrome (PRRS) virus and uses
thereof. US Patent 6,500,662.
Calvert, J.G., Sheppard, M.G., Welch, S.-K.W., 2003. Infectious cDNA clone of North
American porcine reproductive and respiratory syndrome (PRRS) virus and uses
thereof. US Patent Application 20030157689.
Christianson, W.T., Joo, H., 1994. Porcine reproductive and respiratory syndrome: a
review. Swine Health Production 2 (2), 10–28.
Curtis, K.M., Yount, B., Sims, A.C., Baric, R.S., 2004. Reverse genetic analysis of the
transcription regulatory sequence of the coronavirus transmissible gastroenteritis
virus. J. Virol. 78, 6061–6066.
De Rijk, P., Wuyts, J., DeWachter, R., 2003. RnaViz2: an improved representation of RNA
secondary structure. Bioinformatics 19 (2), 299–300.
de Vries, A.A., Glaser, A.L., Raamsman, M.J., de Haan, C.A., Sarnataro, S., Godeke, G.J.,
Rottier, P.J., 2000. Genetic manipulation of equine arteritis virus using full-length
cDNA clones: separation of overlapping genes and expression of a foreign epitope.
Virology 270 (1), 84–97.
de Vries, A.A., Glaser, A.L., Raamsman, M.J., Rottier, P.J., 2001. Recombinant equine
arteritis virus as an expression vector. Virology 284 (2), 259–276.
Done, S.H., Paton, D.J., 1995. Porcine reproductive and respiratory syndrome: clinical
disease, pathology and immunosuppression. Vet. Rec. 136 (2), 32–35.
Fang, Y., Faaberg, K.S., Rowland, R.R., Christopher-Hennings, J., Pattnaik, A.K., Osorio, F.,
Nelson, E.A., 2006a. Construction of a full-length cDNA infectious clone of a
European-like Type 1 PRRSV isolated in the U.S. Adv. Exp. Med. Biol. 581,
605–608.
Fang, Y., Rowland, R.R., Roof, M., Lunney, J.K., Christopher-Hennings, J., Nelson, E.A.,
2006b. A full-length cDNA infectious clone of North American type 1 porcine
reproductive and respiratory syndrome virus: expression of green ﬂuorescent
protein in the Nsp2 region. J. Virol. 80 (23), 11447–11455.
Gao, F., Yao, H.C., Sun, Z., Wang, J.Y., Yuan, S.S., 2007. Reverse genetic manipulation for 5′
UTR sequence of porcine reproductive and respiratory syndrome virus. Veterinary
Science in China 37, 655–660.
GrootBramel-Verheije,M.H., Rottier, P.J.,Meulenberg, J.J., 2000. Expressionofa foreignepitope
by porcine reproductive and respiratory syndrome virus. Virology 278 (2), 380–389.
Han, J., Liu, G., Wang, Y., Faaberg, K.S., 2007. Identiﬁcation of nonessential regions of the
nsp2 replicase protein of porcine reproductive and respiratory syndrome virus
strain VR-2332 for replication in cell culture. J. Virol. 81 (18), 9878–9890.
Keffaber, K.K., 1989. Reproductive failure of unknown etiology. Am. Assoc. Swine Pract.
Newsl. 1, 1–9.
Kim, D.Y., Calvert, J.G., Chang, K.O., Horlen, K., Kerrigan, M., Rowland, R.R., 2007.
Expression and stability of foreign tags inserted into nsp2 of porcine reproductive
and respiratory syndrome virus (PRRSV). Virus. Res. 128 (1–2), 106–114.
Mardassi, H., Massie, B., Dea, S., 1996. Intracellular synthesis, processing, and transport
of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory
syndrome virus. Virology 221 (1), 98–112.Meng, X.J., Paul, P.S., Halbur, P.G., Morozov, I., 1995. Sequence comparison of open
reading frames 2 to 5 of low and high virulence United States isolates of porcine
reproductive and respiratory syndrome virus. J. Gen. Virol. 76 (Pt 12), 3181–3188.
Meulenberg, J.J., 2000. PRRSV, the virus. Vet. Res. 31 (1), 11–21.
Meulenberg, J.J., Bos-de Ruijter, J.N., Wensvoort, G., Moormann, R.J., 1998. An infectious
cDNA clone of porcine reproductive and respiratory syndrome virus. Adv. Exp. Med.
Biol. 440, 199–206.
Meulenberg, J.J., Hulst, M.M., de Meijer, E.J., Moonen, P.L., den Besten, A., de Kluyver, E.P.,
Wensvoort, G., Moormann, R.J., 1993. Lelystad virus, the causative agent of porcine
epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV.
Virology 192 (1), 62–72.
Meulenberg, J.J., Petersen-den Besten, A., 1996. Identiﬁcation and characterization of a
sixth structural protein of Lelystad virus: the glycoprotein GP2 encoded by ORF2 is
incorporated in virus particles. Virology 225 (1), 44–51.
Morozov, I., Meng, X.J., Paul, P.S., 1995. Sequence analysis of open reading frames (ORFs)
2 to 4 of a U.S. isolate of porcine reproductive and respiratory syndrome virus. Arch.
Virol. 140 (7), 1313–1319.
Mounir, S., Mardassi, H., Dea, S., 1995. Identiﬁcation and characterization of the porcine
reproductive and respiratory virus ORFs 7, 5 and 4 products. Adv. Exp. Med. Biol.
380, 317–320.
Nelsen, C.J., Murtaugh, M.P., Faaberg, K.S., 1999. Porcine reproductive and respiratory
syndrome virus comparison: divergent evolution on two continents. J. Virol. 73 (1),
270–280.
Nelson, E.A., Christopher-Hennings, J., Drew, T.,Wensvoort, G., Collins, J.E., Benﬁeld, D.A.,
1993. Differentiation of U.S. and European isolates of porcine reproductive and
respiratory syndrome virus by monoclonal antibodies. J. Clin. Microbiol. 31,
3184–3189.
Nielsen, H.S., Liu, G., Nielsen, J., Oleksiewicz, M.B., Botner, A., Storgaard, T., Faaberg, K.S.,
2003. Generation of an infectious clone of VR-2332, a highly virulent North
American-type isolate of porcine reproductive and respiratory syndrome virus.
J. Virol. 77 (6), 3702–3711.
Pasternak, A.O., Spaan, W.J., Snijder, E.J., 2004. Regulation of relative abundance of
arterivirus subgenomic mRNAs. J. Virol. 78 (15), 8102–8113.
Pasternak, A.O., Spaan, W.J., Snijder, E.J., 2006. Nidovirus transcription: how to make
sense…? J. Gen. Virol. 87 (Pt 6), 1403–1421.
Saito, A., Kanno, T., Murakami, Y., Muramatsu, M., Yamaguchi, S., 1996. Characteristics of
major structural protein coding gene and leader-body sequence in subgenomic
mRNA of porcine reproductive and respiratory syndrome virus isolated in Japan.
J. Vet. Med. Sci. 58 (4), 377–380.
Shanmukhappa, K., Majhdi, F., Kapil, S., 2000. Production, characterization, and uses of
monoclonal antibodies against porcine reproductive and respiratory syndrome
virus 3′ untranslated region and nucleoprotein RNA binding proteins. Hybridoma
19 (3), 263–267.
Snijder, E.J., Meulenberg, J.J., 1998. The molecular biology of arteriviruses. J. Gen. Virol.
79 (Pt 5), 961–979.
Sola, I., Moreno, J., Alonso, S., Zuniga, S., Enjuanes, L., 2005. Role of nucleotides
immediately ﬂanking the transcription-regulating sequence core in coronavirus
subgenomic mRNA synthesis. J. Virol. 79 (4), 2506–2516.
Sun, Z., Wang, J.Y., Zhang, J.W., Qin, A.J., Yuan, S.S., 2007. [Identiﬁcation of porcine
reproductive and respiratory syndrome virus regulatory sequence in 3′-untrans-
lated region]. Wei Sheng Wu Xue Bao 47 (5), 774–778.
Tian, K., Yu, X., Zhao, T., Feng, Y., Cao, Z., Wang, C., Hu, Y., Chen, X., Hu, D., Tian, X., Liu, D.,
Zhang, S., Deng, X., Ding, Y., Yang, L., Zhang, Y., Xiao, H., Qiao, M., Wang, B., Hou, L.,
Wang, X., Yang, X., Kang, L., Sun, M., Jin, P., Wang, S., Kitamura, Y., Yan, J., Gao, G.F.,
2007. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS
in China and molecular dissection of the unique hallmark. PLoS. ONE 2 (6), e526.
Thiel, H.J., Meyers, G., Stark, R., Tautz, N., Rumenapf, T., Unger, G., Conzelmann, K.K.,
1993. Molecular characterization of positive-strand RNA viruses: pestiviruses and
the porcine reproductive and respiratory syndrome virus (PRRSV). Arch. Virol.
Suppl. 7, 41–52.
Tong, G.Z., Zhou, Y.J., Hao, X.F., Tian, Z.J., An, T.Q., Qiu, H.J., 2007. Highly pathogenic
porcine reproductive and respiratory syndrome, China. Emerg. Infect. Dis. 13 (9),
1434–1436.
Truong, H.M., Lu, Z., Kutish, G.F., Galeota, J., Osorio, F.A., Pattnaik, A.K., 2004. A highly
pathogenic porcine reproductive and respiratory syndrome virus generated from
an infectious cDNA clone retains the in vivo virulence and transmissibility
properties of the parental virus. Virology 325 (2), 308–319.
van Dinten, L.C., den Boon, J.A., Wassenaar, A.L., Spaan, W.J., Snijder, E.J., 1997. An
infectious arterivirus cDNA clone: identiﬁcation of a replicase point mutation that
abolishes discontinuous mRNA transcription. Proc. Natl. Acad. Sci. U. S. A. 94 (3),
991–996.
van Marle, G., Dobbe, J.C., Gultyaev, A.P., Luytjes, W., Spaan, W.J., Snijder, E.J., 1999.
Arterivirus discontinuous mRNA transcription is guided by base pairing between
sense and antisense transcription-regulating sequences. Proc. Natl. Acad. Sci. U. S. A.
96 (21), 12056–12061.
Verheije, M.H., Kroese, M.V., Rottier, P.J., Meulenberg, J.J., 2001. Viable porcine
arteriviruses with deletions proximal to the 3′ end of the genome. J. Gen. Virol.
82 (Pt 11), 2607–2614.
Verheije, M.H., Olsthoorn, R.C., Kroese, M.V., Rottier, P.J., Meulenberg, J.J., 2002a. Kissing
interaction between 3′ noncoding and coding sequences is essential for porcine
arterivirus RNA replication. J. Virol. 76 (3), 1521–1526.
Verheije, M.H., Welting, T.J., Jansen, H.T., Rottier, P.J., Meulenberg, J.J., 2002b. Chimeric
arteriviruses generated by swapping of the M protein ectodomain rule out a role of
this domain in viral targeting. Virology 303 (2), 364–373.
Wang, Y., Liang, Y., Han, J., Burkhart, K.M., Vaughn, E.M., Roof, M.B., Faaberg, K.S.,
2008. Attenuation of porcine reproductive and respiratory syndrome virus strain
31D. Yu et al. / Virology 383 (2009) 22–31MN184 using chimeric construction with vaccine sequence. Virology. 371 (2),
418–429.
Wensvoort, G., Terpstra, C., Pol, J.M., ter Laak, E.A., Bloemraad, M., de Kluyver, E.P.,
Kragten, C., van Buiten, L., den Besten, A., 1991. Mystery swine disease in The
Netherlands: the isolation of Lelystad virus. Vet. Q. 13, 121–130.
Wootton, S., Yoo, D., Rogan, D., 2000. Full-length sequence of a Canadian porcine
reproductive and respiratory syndrome virus (PRRSV) isolate. Arch. Virol. 145 (11),
2297–2323.
Wu, W.H., Fang, Y., Rowland, R.R., Lawson, S.R., Christopher-Hennings, J., Yoon, K.J.,
Nelson, E.A., 2005. The 2b protein as a minor structural component of PRRSV. Virus
Res. 114 (1–2), 177–181.Yount, B., Roberts, R.S., Lindesmith, L., Baric, R.S., 2006. Rewiring the severe acute
respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a
recombination-resistant genome. Proc. Natl. Acad. Sci. U. S. A. 103 (33), 12546–12551.
Yuan, S., Murtaugh, M.P., Faaberg, K.S., 2000. Heteroclite subgenomic RNAs are
produced in porcine reproductive and respiratory syndrome virus infection.
Virology 275 (1), 158–169.
Yuan, S., Wei, Z., 2008. Construction of infectious cDNA clones of PRRSV: separation of
coding regions for nonstructural and structural proteins. Sci. China C. Life Sci. 51 (3),
271–279.
Zuker, M., 2003. Mfold web server for nucleic acid folding and hybridization prediction.
Nucleic Acids Res. 31 (13), 3406–3415.
